Exercise to Boost Response to Checkpoint Blockade Immunotherapy

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cutaneous MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
Interventions
OTHER

Exercise Test

Supervised pedaling on an ergometer (stationary bike) at a moderate pace for a goal of 30 minutes. The exercise test will be scheduled at infusion visits 1, 6, and 12 or 1 and 3 over the treatment cycle, depending on the group assignment.

Trial Locations (1)

32804

RECRUITING

AdventHealth Translational Research Institute, Orlando

All Listed Sponsors
lead

AdventHealth Translational Research Institute

OTHER